New partner for scrapie genotyping services announced
Athens - The Greek government announced in August a collaborative agreement between its contractor Antisel A. Selidis and US-based Genaissance Pharmaceuticals in the field of scrapie genotyping.
Under the terms of the agreement, Genaissance will be the exclusive genotyping provider for Antisel, which has been awarded a contract by the Hellenic Ministry of Rural Development and Food. The contract derives from a European Union mandate to establish a breeding programme in sheep that confers resistance to scrapie.
Scrapie is a fatal, degenerative disease affecting the central nervous system of sheep and goats. It is among a number of diseases classified as transmissible spongi form encephalopathies (TSE).